20 - feb. - 2020
Next Thursday, February 27, the next conference of the fourth edition of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC given by Dr. Martin will be held with the title “MTBVAC a new vaccine against tuberculosis, from laboratory to clinical trials of efficacy in endemic countries ”.
Carlos Martín is Professor of Microbiology at the Faculty of Medicine of the University of Zaragoza and directs the Group of Genetics of Mycobacteria (TBVI), belonging to the CIBER of Respiratory Diseases of the Carlos III Health Institute. His work focuses on the research and development of new live vaccines against tuberculosis. Dr. Martín and his team have built and characterized the MTBVAC vaccine, now in clinical trials. He is currently working on various research projects funded by the European Union in tuberculosis collaborating with research groups in Europe, Africa and Latin America. He is a member of the Research & Innovation group of the Tuberculosis Vaccines Initiative (TBVI) http://www.tbvi.eu/ with more than 25 years of experience in mycobacterial genetics.
Dr. Martín trained at the Pasteur Institute in Paris, where he was a permanent researcher in the team of Professor Brigitte Gicquel, pioneer of genetic studies of tuberculosis. His previous research training focused on studies of resistance mechanisms with Professor Juan María García Lobo and transposition in bacteria with Professor Fernando de la Cruz in the Department of Biochemistry and Molecular Biology of the University of Cantabria.
He has published more than one hundred and fifty international publications cited more than 8,500 times in recent years (ResearcherID: A-7283-2008). Dr. Martin's research has been continually funded by the National and European Union Research Programs since the formation of his Research Group in 1992 (TBVI).
The conference is open to all the public of Santander who wants to participate. It will take place on Thursday, February 27 at the Marqués de Valdecilla University Hospital, in the Téllez Plasencia Hall (Hall 16) at 8.15 am in the morning.
Promoting a discussion forum on the current advances in biomedicine, the rapporteur will remain in our Community throughout the day of the session, to exchange experiences with members of the scientific and clinical community of Santander, and to visit the research centers of our community to meet interested scientists firsthand.
The speaker is invited by Dr. Alain Ocampo, Miguel Servet's contract at the Marqués de Valdecilla Research Institute (IDIVAL) in the group Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Clinical Microbiology. Those professionals who wish to have a meeting with the speaker during their visit can contact through the following e-mails: email@example.com or firstname.lastname@example.org